$1.04
-0.01-0.95%
In chiusura: Nov 20, 4:00 PM EST
$1.04
N/A
Post-mercato: Nov 20, 9:14 AM EST

The average analyst price target for ProQR Therapeutics is $8, 669.2% above the current price. Of 10 analysts, 9 rate it Buy and 1 Hold. Targets range from $2 to $14. The latest change came on Oct 1, 2026, when HC Wainwright & Co. lowered its price target on ProQR Therapeutics from $12 to $8 and kept a Buy rating.
Price Target Range — 10 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months